Source link : https://newshealth.biz/health-news/real-world-data-support-for-lecanemab-in-early-ad/

A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow the course of Alzheimer’s disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/real-world-data-support-lecanemab-early-ad-2025a1000y4o?src=rss Author : Publish date : 2025-12-05 13:07:00 Copyright for syndicated content belongs to the linked Source.

The post Real-World Data Support for Lecanemab in Early AD first appeared on News Health.

—-

Author : News Health

Publish date : 2025-12-05 13:07:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version